Frequency of all Adverse Events 6 years [clinicaltrials_resource:4a83506a889df9d5ebfaf85810868085]
750mg Intravenous, monthly and individual dosing schedule
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Frequency of all Adverse Events 6 years [clinicaltrials_resource:4a83506a889df9d5ebfaf85810868085]
750mg Intravenous, monthly and individual dosing schedule
Bio2RDF identifier
4a83506a889df9d5ebfaf85810868085
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4a83506a889df9d5ebfaf85810868085
measure [clinicaltrials_vocabulary:measure]
Frequency of all Adverse Events
time frame [clinicaltrials_vocabulary:time-frame]
description
750mg Intravenous, monthly and individual dosing schedule
identifier
clinicaltrials_resource:4a83506a889df9d5ebfaf85810868085
title
Frequency of all Adverse Events 6 years
@en
type
label
Frequency of all Adverse Event ...... 3506a889df9d5ebfaf85810868085]
@en